Executive Summary to EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
- PMID: 26414233
- PMCID: PMC4702495
- DOI: 10.1210/er.2015-1093
Executive Summary to EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
Abstract
This Executive Summary to the Endocrine Society's second Scientific Statement on environmental endocrine-disrupting chemicals (EDCs) provides a synthesis of the key points of the complete statement. The full Scientific Statement represents a comprehensive review of the literature on seven topics for which there is strong mechanistic, experimental, animal, and epidemiological evidence for endocrine disruption, namely: obesity and diabetes, female reproduction, male reproduction, hormone-sensitive cancers in females, prostate cancer, thyroid, and neurodevelopment and neuroendocrine systems. EDCs such as bisphenol A, phthalates, pesticides, persistent organic pollutants such as polychlorinated biphenyls, polybrominated diethyl ethers, and dioxins were emphasized because these chemicals had the greatest depth and breadth of available information. The Statement also included thorough coverage of studies of developmental exposures to EDCs, especially in the fetus and infant, because these are critical life stages during which perturbations of hormones can increase the probability of a disease or dysfunction later in life. A conclusion of the Statement is that publications over the past 5 years have led to a much fuller understanding of the endocrine principles by which EDCs act, including nonmonotonic dose-responses, low-dose effects, and developmental vulnerability. These findings will prove useful to researchers, physicians, and other healthcare providers in translating the science of endocrine disruption to improved public health.
References
Publication types
MeSH terms
Substances
Grants and funding
- U01 ES020886/ES/NIEHS NIH HHS/United States
- R01 ES023254/ES/NIEHS NIH HHS/United States
- R01 ES019178/ES/NIEHS NIH HHS/United States
- ES023254/ES/NIEHS NIH HHS/United States
- R01 ES010026/ES/NIEHS NIH HHS/United States
- R01 CA172220/CA/NCI NIH HHS/United States
- ES020908/ES/NIEHS NIH HHS/United States
- ES020662/ES/NIEHS NIH HHS/United States
- CA172220/CA/NCI NIH HHS/United States
- R56 ES020662/ES/NIEHS NIH HHS/United States
- ES020886/ES/NIEHS NIH HHS/United States
- U01 ES020908/ES/NIEHS NIH HHS/United States
- RC2 ES018758/ES/NIEHS NIH HHS/United States
- R01 ES020662/ES/NIEHS NIH HHS/United States
- R01 ES022071/ES/NIEHS NIH HHS/United States
- ES019178/ES/NIEHS NIH HHS/United States
- ES010026/ES/NIEHS NIH HHS/United States
- ES02207/ES/NIEHS NIH HHS/United States
- R56 ES010026/ES/NIEHS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous